Albemarle (ALB) EBIT (2009 - 2026)

Albemarle (ALB) has reported EBIT for 18 consecutive years, with $658.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 1286.15% year-over-year to $658.8 million; the trailing twelve-month figure through Jun 2026 stood at $207.2 million (up 119.98% YoY), and the FY2025 full-year result was -$367.1 million, up 79.34% from the prior year.
• EBIT advanced to $658.8 million in Q2 2026 per ALB's latest filing, from $406.7 million in the prior quarter.
• Across five years, EBIT topped out at $1.1 billion in Q1 2023 and bottomed at -$1.1 billion in Q3 2024.
• Historically, EBIT has averaged $67.8 million across 5 years, with a median of $61.9 million in 2025.
• The sharpest annual moves came in 2022 and 2025: EBIT jumped 2762.56% in 2022, then sank 21327.42% in 2025.
• Over 5 years, EBIT stood at $833.0 million in 2022, then tumbled by 202.02% to -$849.9 million in 2023, then jumped by 100.52% to $4.4 million in 2024, then tumbled by 21327.42% to -$934.4 million in 2025, then jumped by 170.5% to $658.8 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $658.8 million, $406.7 million, and -$934.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.